期刊
JOURNAL OF INFECTIOUS DISEASES
卷 208, 期 10, 页码 1717-1728出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jit358
关键词
posaconazole; localization; pharmacokinetics; endoplasmic reticulum; epithelial cells; Aspergillus; postantifungal effect; hydrophobin rodA
资金
- Merck Canada
- Fonds de Recherche en Sante du Quebec
- Burroughs Welcome Fund
- National Institutes of Health [R01AI073829]
- McGill University
Background. The antifungal posaconazole concentrates within host cells and protects against Aspergillus fumigatus. The specific subcellular location of posaconazole and the mechanism by which cell-associated posaconazole inhibits fungal growth remain uncharacterized. Methods. Posaconazole was conjugated with the fluorophore boron-dipyrromethene (BDP-PCZ). A549 pulmonary epithelial cells and A. fumigatus were exposed to BDP-PCZ individually and in coculture. BDP-PCZ subcellular localization and trafficking were observed using confocal microscopy and flow cytometry. Results. BDP-PCZ concentrated within A549 cell membranes, and in particular within the endoplasmic reticulum. Epithelial cell-associated BDP-PCZ rapidly transferred to and concentrated within A. fumigatus cell membranes on contact. BDP-PCZ transfer to conidia did not require phagocytosis and was markedly enhanced by the conidial hydrophobin RodA. Within AF, BDP-PCZ also concentrated in membranes including the endoplasmic reticulum and colocalized with the azole target enzyme CYP51a. Concentration of BDP-PCZ within host and fungal cell membranes persisted for > 48 hours and could be competitively inhibited by posaconazole but not voriconazole. Conclusions. Posaconazole concentrates within host cell membranes and rapidly transfers to A. fumigatus, where it accumulates to high concentrations and persists at the site of its target enzyme. These intracellular and intercellular pharmacokinetic properties probably contribute to the efficacy of PCZ.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据